Patents by Inventor James E. Bailey

James E. Bailey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10953626
    Abstract: A method of forming a coating layer on a fibrous mat to make a coated article includes depositing a coating composition on a carrier material and at least partially embedding a first major surface of a fibrous mat in the coating composition, the fibrous mat including a plurality of mat fibers. The coating composition is at least partially hardened to form a coating layer at the first major surface of the fibrous mat. A second major surface of the fibrous mat opposite the first major surface includes an uncoated portion of the plurality of mat fibers.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: March 23, 2021
    Assignee: AXALTA COATING SYSTEMS IP CO., LLC
    Inventors: John E. Kirkwood, Michael D. Foster, Herbert D. Temple, James E. Bailey, Michael Deal, Charles R. Harrison, Christopher J. Sanders, Yi-Hsien Teng
  • Patent number: 10344478
    Abstract: An adhesive binder composition for adhering a paper sheet to a gypsum article with a gypsum layer having at least one paper sheet on a major surface thereof. The adhesive binder composition includes a polymeric adhesive and at least one surfactant. The adhesive binder composition resides at a boundary between the gypsum layer and the paper sheet.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: July 9, 2019
    Assignees: Axalta Coating Systems IP Co., LLC, Georgia-Pacific Gypsum, LLC
    Inventors: Michael D. Foster, Nellie Moretz, James E. Bailey, John E. Kirkwood, Brian W. Bland, Ali Fadhel
  • Publication number: 20170341337
    Abstract: A method of forming a coating layer on a fibrous mat to make a coated article includes depositing a coating composition on a carrier material and at least partially embedding a first major surface of a fibrous mat in the coating composition, the fibrous mat including a plurality of mat fibers. The coating composition is at least partially hardened to form a coating layer at the first major surface of the fibrous mat. A second major surface of the fibrous mat opposite the first major surface includes an uncoated portion of the plurality of mat fibers.
    Type: Application
    Filed: November 20, 2015
    Publication date: November 30, 2017
    Inventors: John E. Kirkwood, Michael D. Foster, Herbert D. Temple, James E. Bailey, Michael Deal, Charles R. Harrison, Christopher J. Sanders, Yi-Hsien Teng
  • Patent number: 9718885
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: August 1, 2017
    Assignee: Roche GlycArt AG
    Inventors: Pablo Umaña, Joël Jean-Mairet, James E. Bailey
  • Patent number: 9631023
    Abstract: The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: April 25, 2017
    Assignee: ROCHE GLYCART AG
    Inventors: Pablo Umaña, Joël Jean-Mairet, James E. Bailey
  • Publication number: 20160272719
    Abstract: The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.
    Type: Application
    Filed: March 24, 2016
    Publication date: September 22, 2016
    Applicant: Roche GlycArt AG
    Inventors: Pablo Umaña, Joël Jean-Mairet, James E. Bailey
  • Publication number: 20160208009
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Application
    Filed: July 10, 2015
    Publication date: July 21, 2016
    Applicant: Roche GlycArt AG
    Inventors: Pablo Umana, Joël Jean-Mairet, James E. Bailey
  • Patent number: 9321843
    Abstract: The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: April 26, 2016
    Assignee: Roche Glycart AG
    Inventors: Pablo Umaña, Joël Jean-Mairet, James E. Bailey
  • Publication number: 20150274837
    Abstract: The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.
    Type: Application
    Filed: March 23, 2015
    Publication date: October 1, 2015
    Applicant: Roche GlycArt AG
    Inventors: Pablo UMAÑA, Joël JEAN-MAIRET, James E. BAILEY
  • Patent number: 9139654
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: September 22, 2015
    Assignee: Roche GlyeArt AG
    Inventors: Pablo Umaña, Joël Jean-Mairet, James E. Bailey, M. Sean Bailey
  • Publication number: 20150064488
    Abstract: An adhesive binder composition for adhering a paper sheet to a gypsum article with a gypsum layer having at least one paper sheet on a major surface thereof. The adhesive binder composition includes a polymeric adhesive and at least one surfactant. The adhesive binder composition resides at a boundary between the gypsum layer and the paper sheet.
    Type: Application
    Filed: August 26, 2014
    Publication date: March 5, 2015
    Inventors: Michael D. Foster, Nellie Moretz, James E. Bailey, John E. Kirkwood, Brian W. Bland, Ali Fadhel
  • Publication number: 20150064433
    Abstract: Membrane-ready fibrous faced gypsum panels, methods, and apparatus are provided. The panels include a first fibrous mat having a first surface and a second surface, a second fibrous mat having a first surface and a second surface, a gypsum core in contact with the second surfaces of the first and second fibrous mats, and a material coating that covers the first surface of the first fibrous mat and forms a substantially smooth outer surface.
    Type: Application
    Filed: August 26, 2014
    Publication date: March 5, 2015
    Inventors: Michael D. Foster, Brian W. Bland, Ali Fadhel, James E. Bailey, Shaobing Wu
  • Publication number: 20110294984
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Application
    Filed: December 23, 2010
    Publication date: December 1, 2011
    Applicant: Roche GlycArt AG
    Inventors: Pablo UMANA, Joel Jean-Mairet, James E. Bailey
  • Publication number: 20110293609
    Abstract: The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.
    Type: Application
    Filed: August 2, 2011
    Publication date: December 1, 2011
    Applicant: Roche GlycArt AG
    Inventors: Pablo UMAÑA, Jöel Jean-Mairet, James E. Bailey
  • Patent number: 8021856
    Abstract: The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: September 20, 2011
    Assignee: Roche GlycArt AG
    Inventors: Pablo Umaña, Joël Jean-Mairet, James E. Bailey, M. Sean Bailey, legal representative
  • Publication number: 20110142825
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Application
    Filed: May 28, 2010
    Publication date: June 16, 2011
    Applicant: ROCHE GLYCART AG
    Inventors: PABLO UMAÑA, JOËL JEAN-MAIRET, JAMES E. BAILEY, M. SEAN BAILEY
  • Patent number: 7906329
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: March 15, 2011
    Assignee: Glycart Biotechnology AG
    Inventors: Pablo Umana, Joel Jean-Mairet, James E Bailey
  • Publication number: 20090304690
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Application
    Filed: March 23, 2009
    Publication date: December 10, 2009
    Applicant: GLYCART BIOTECHNOLOGY AG
    Inventors: PABLO UMANA, JOEL JEAN-MAIRET, JAMES E. BAILEY, Sean Bailey
  • Patent number: 7517670
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: April 14, 2009
    Assignee: GlycArt Biotechnology AG
    Inventors: Pablo Umaña, Joël Jean-Mairet, M. Sean Bailey, legal representative, James E Bailey
  • Publication number: 20040072290
    Abstract: The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
    Type: Application
    Filed: May 14, 2003
    Publication date: April 15, 2004
    Applicant: GlycArt Biotechnology AG
    Inventors: Pablo Umana, Joel Jean-Mairet, James E. Bailey